Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry - Scorecard - MDSpire

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

  • By

  • Mustafa Yildirim

  • Christian Salbach

  • Johannes Dürr

  • Matthias Mueller-Hennessen

  • Hugo A. Katus

  • Norbert Frey

  • Evangelos Giannitsis

  • April 15, 2026

  • 0 min

Share

Clinical Scorecard: Insights from the HERA-FIB Registry on Type 1 and Type 2 NSTEMI in Patients with Atrial Fibrillation

At a Glance

CategoryDetail
ConditionNon-ST-Elevation Myocardial Infarction (NSTEMI) in patients with Atrial Fibrillation (AF)
Key MechanismsType 1 MI involves coronary plaque rupture or thrombosis requiring intervention; Type 2 MI results from myocardial oxygen supply-demand mismatch without necessarily coronary stenosis
Target PopulationAdults with atrial fibrillation presenting with symptoms suggestive of acute coronary syndrome
Care SettingTertiary care hospital with systematic invasive coronary angiography strategy

Key Highlights

  • Systematic coronary angiography was performed in 81.7% of AF patients with NSTEMI to accurately differentiate type 1 and type 2 MI.
  • Type 2 MI diagnosis in AF patients is often based on troponin elevation and clinical criteria without routine angiographic evaluation.
  • The study used the 4th Universal Definition of Myocardial Infarction and ESC hs-cTnT protocols for diagnosis and risk stratification.

Guideline-Based Recommendations

Diagnosis

  • Apply 4th Universal Definition of Myocardial Infarction (UDMI) criteria requiring hs-cTnT elevation above 99th percentile with rise/fall and ischemic symptoms or ECG/imaging changes.
  • Use coronary angiography to differentiate type 1 MI (plaque rupture/thrombosis) from type 2 MI (oxygen supply-demand mismatch).
  • Employ ESC 0/1h, 0/2h, or 0/3h hs-cTnT algorithms for early triage and risk stratification.

Management

  • Early invasive coronary angiography is standard for NSTEMI patients unless contraindicated by severe comorbidities or patient refusal.
  • Treatment decisions should consider angiographic findings to guide intervention in type 1 MI.

Monitoring & Follow-up

  • Serial hs-cTnT measurements per ESC protocols to confirm diagnosis and monitor myocardial injury dynamics.

Risks

  • Under-recognition of type 1 MI may occur if angiography is not performed.
  • Misclassification of MI subtype can affect treatment and outcomes.

Patient & Prescribing Data

Adults with atrial fibrillation presenting with NSTEMI symptoms undergoing coronary angiography

High rate of coronary angiography minimizes selection bias and allows accurate infarct subtype classification, informing appropriate management.

Clinical Best Practices

  • Perform coronary angiography in AF patients with NSTEMI to accurately classify MI subtype.
  • Use high-sensitivity cardiac troponin assays and ESC rapid algorithms for early diagnosis and risk stratification.
  • Exclude patients with advanced comorbidities or contraindications from invasive procedures to balance risks and benefits.
  • Maintain systematic data collection and follow-up to assess clinical outcomes including mortality, recurrent MI, stroke, and bleeding.

References

Original Source(s)

Related Content